The article aims at giving a comprehensive overview on controlling communicable diseases (CCD) and discusses the implications of providing CCD as a global public good (GPG). After a short introductory summary of
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During the 19th century the increasing importance of international trade, the growing speed of travel and transport and the growing population in harbour cities with a still low level of hygiene (waste disposal, drinking water) resulted in a growing international concern about sanitary matters [2] . Between 1851 and 1938 fourteen International Sanitary Conferences took place to control the international spread of epidemics, primarily of Cholera, later on also including plagues and yellow fever with a minimal impediment of trade. At the 7th of these conferences in 1892 a first binding International Sanitary Convention (ISC) was signed, focussing on quarantine in the case of cholera, supplemented by another convention in 1897 on plague [3] and in 1912 also yellow fever was included [4] . In 1907 the Office International d'Hygiène Publique was established, the first global permanent health organization with the task to collect epidemiological intelligence and to implement the ISCs. In 1948 this mandate was officially transferred to the newly established World Health Organization (WHO) and the ISC renamed International Sanitary (since 1969 Health) Regulations (ISR/IHR). In 1951 new comprehensive ISR were adopted by WHO with the renewed aim of "successful control of international transmission of pestilential diseases, as well as removal of hindrances to international travel" through "immediate and complete information from all parts of the world" [5] , while a WHO memorandum stressed "A community is more effectively protected…by its own public health services than by sheltering behind a barrier of quarantine measures" [5] . The ISR referred to six "quarantinable diseases": plague, cholera, yellow fever, smallpox, typhus and relapsing fever [6] .
Various revisions of the ISR/IHR until 1983 did not strengthen their importance in global health. On the contrary, they were reduced to coordinating action in the case of only three diseases, smallpox being successfully eradicated and typhus and relapsing fever reduced in their international impact. This process mirrored the expectations of a generally reduced importance of infectious diseases (at least from the perspective of high-income countries, HICs) being seen "as the diseases of the poor" while the universal rise of non-communicable diseases created an increasing concern. Furthermore the idea of eradicating the most serious communicable diseases (smallpox, polio, and some others) played an important role. The rise of new communicable diseases, in particularly HIV/AIDS, and the realization that new infectious diseases transmitted from wild animals and adapting to human hosts (such as Ebola, West-Nile-Virus, Rift-Valley-Fever) will always constitute an important risk to human health.
Taking into consideration the growing mobility-including more intense and accelerated contacts with remote regions-as a risk for spreading diseases, and the assumed growing threat of bio-terror, new negotiations on IHR started in 1995. Assuming that, in principle, transborder mobility is a necessary condition for economic welfare and personal freedom, and anticipating further that mobility might lead to an Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002
Med One 4 of 37 unintended spread of infectious agents, the attainment of CCD as a global public good (GPG) has to be seen as an important goal of collective action in a global interconnected world. The international concern about these threats has also been expressed in the expanding discourse of global health security (see Section "Health Security").
Though the number of publications on CCD as a GPG has remained rather modest, in my view this link allows the most complete perspective encompassing the elements of CCD, specific goods for CCD and the problems related to its provision. I will use the most comprehensive publication on global public goods for health by Richard Smith et al. [7] as a starting-point (for general issues in particular chapters 1, 13 and 14) . A short introduction to the problematic of public goods, their provision on the global level and with respect to global health will be given in the next This will lead to the argument that a comprehensive approach to CCD has to transcend the narrow perspective on controlling specific diseases and the threat of their transnational spread, but ought to include aspects of health systems, universal access to healthcare and the global impact of political instability and conflicts related to bad health, as e.g. in the case of HIV/AIDS and political instability in Africa [8] (Section "TOWARDS AN
INTEGRATED CONTROL OF COMMUNICABLE DISEASES AS A GPG"),
which is important for the discussion of financial needs (Section "FINANCE OF CCD"). What then, however, is specific to the control for communicable compared to that of non-communicable diseases? This is a complicated issue, in particular as research has increasingly corroborated strong links between communicable diseases (CDs) and noncommunicable diseases (NCDs). One important aspect is the observation that while NCDs are rather closely linked to processes of modernization and changes in life-style caused by globalization, CDs produce unforeseeable threats to development processes, and the persistence of many CDs is closely related to the persistence of poverty and low-standard health systems in low income societies.
PUBLIC (COMMON) GOODS
The idea of a common good which may be "in the highest degree advantageous to a great society" but is "of such a nature that the profits could never repay the expense to any individual or small number of individuals" ([9], p. 559) has been raised by Adam Smith and in a similar understanding already by David Hume ([10] , p. 383-384). The actually prevailing definition of a public good (being neither rival nor excludable once the good is provided) builds on contributions by Richard Musgrave [11, 12] and Paul Samuelson [13] since the end 1930s. Providing public goods implies a collective action problem [14] . As access cannot be denied Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002
Med One 5 of 37 to anyone, public goods will not be provided through market dynamics but will only be made available through collective action. This implies mechanisms to enforce the provision of the resources necessary to guarantee a secure availability of the respective goods. As there will always be the risk of free-riders, public goods are mostly provided by the state (at different levels of national societies) which disposes of the coercive means to make people pay according to rules politically determined. This still entails a tendency of public goods to be underfinanced due to a competition for a host of public services by different political constituencies, and a reluctance to contribute to financing state activities. While market failure constitutes the startingpoint of the idea of public goods, there is the risk of government failure due to rent-seeking by policy-makers and bureaucrats which will lead to advantages for influential groups of the population (and a neglect of marginalized sections) or to a lack of public action due to political stalemates.
Furthermore, it has to be taken into account that there are "impure public goods" that are either non-rivalrous in consumption but excludable ("club goods", such as access to specific hospital services) or nonexcludable but rivalrous in consumption (common pool resources, such as many forms of environmental resources, or services of a comprehensive national public health system, which depend on limited financial and human resources [14] [15] [16] [17] . Another qualification refers to so-called access goods. These are (in principle) public goods, "that are only non-excludable to those who have the requisite private goods to access them." Examples are a computer to access the internet, the necessary infrastructure to access clean water or health services" ( [18] , p. 5f.).
"Health" as such is a private good because the individual person is the primary beneficiary of it; the health of a person depends on his/her individual constitution and health-related behaviour. The access to public health care can at best be non-excludable, but due to limited resources will be rivalrous in consumption (i.e., constitutes a case of common pool resources as pointed out by Rocco Palumbo [19] ). Improving the overall health status of a community, however, is a public good: Woodward and Smith point out that there are externalities of the health status of individuals in the field of communicable diseases (preventing one person from getting the disease reduces the risk of infection of others, reduction of disease in one country reduces cross-border transmission, see below,
Section "GPGs for Global Health: Role of Global Health Governance-Variety of Actors, Self-Organization, Flexibility") and with respect to the cumulative impact on economic development ( [18] , p. [10] [11] [12] [13] . This is also implicitly highlighted in the Report of the Commission on Macroeconomics and Health (CMH) which made the point that while on the one hand the level of healthcare depends on socioeconomic development, on the other hand, health also constitutes an important determinant of macroeconomic growth [20] . Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002
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The early discussion on the provision of public goods was primarily linked to the need of public delivery and finance, but public goods can be (co-)financed by other actors. This can take various forms: (1) contributions from actors willing to pay in spite of the option of freeriding, i.e., in general co-financing with non-profit/civil society groups (philanthropy) [21, 22] which voluntarily contribute to their delivery with ethical/solidarity-oriented motivations; (2) outsourcing the provision of goods to private providers which can be for-profit enterprises, but also private partners of health partnerships (PPPs) [23] ; (3) cooperation with other states with the aim of producing international public goods. All three types of sources play an important role in financing global public goods (see following section).
In the earlier discourse it has been assumed that the scope of a public good available to a community results from the sum of individual contributions (basically in form of taxes if the good is provided by the state). The aggregation of contributions, however, varies according to the aggregation technologies used which again are linked to the type of public good required [22, 24, 25] . The eradication of diseases e.g. requires on the one-hand a so called best-shot technology (allowing the development of one most effective vaccine), but on the other hand a weakest-link technology (allowing all countries including the poorest) to implement successful vaccination campaigns. Taking into account that the provision of CCDs is a complex good requiring many different inputs by diverse
actors (see Sections "GPGs for Global Health: Role of Global Health
Governance-Variety of Actors, Self-Organization, Flexibility" and "Control of Communicable Diseases: A Classical Global Public Good?"), the overall aggregation of contributions for CCD cannot be dealt with in this article, which focusses on the attempt to give a comprehensive overview on the wide range of issues involved in CCD.
GLOBAL PUBLIC GOODS
GPG: Definition and Discussion
Kaul et al. postulate that, besides being non-rivalrous in consumption and non-excludable, the benefits of GPGs "are quasi universal in terms of countries (covering more than one group of countries), people (accruing to several, preferable all, populations groups) and generations (extending to both current and future generations, or at least meeting the needs of current generations without foreclosing development options for future generations)" ( [17] , p. 2f.). The third aspect draws on the definition of sustainable development provided by the Brundtland Commission [26] .
While in general, related to national societies, the state is considered to secure the delivery of public goods, based on a legitimate coercive power to raise taxes and to secure the implementation of the necessary regulations, on the global level there is no world state to fulfil this role.
International agreements as the IHR could provide a foundation to the Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002 Med One 7 of 37 delivery of GPGs. There is an extended literature in international relations theory on the possibilities and limitations of international agreements and organizations which cannot be summarized here. A concise overview of IR theories and their view on international cooperation is given by Anne-Marie Slaughter [27] ; a thorough discussion of the growing role of law in world politics can be found in a volume edited by Slaughter, Judith Goldstein, Miles Kahler and Robert O. Keohane [28] .
In a historical perspective, GPGs had been provided mostly in limited technical fields such as postal and other communication services, the protection of the Ozone Layer and the Antarctic Treaty System as limited environmental agreements, and, as referred to above, international sanitary regulations to control the spread of some particularly severe infectious diseases. These are fields where specific common interests among nations prevailed because of limited costs to observe agreed rules.
Concerning international/transnational norms in more complex and sovereignty-affecting policy fields, such as international peace-keeping, however, implementation will depend on a strong hegemonic dominance of one nation or a stable alliance of nations [29] [30] [31] . The US hegemony, largely supported by the EU and Japan, allowed the establishment of the international monetary regime and the WTO trade regime, but this regime has been losing effectiveness when hegemony structures became embattled through the growing power of emerging economies. This relates to health issues in particular in the field of intellectual property rights and access to medicines [32, 33] .
Providing GPGs related to reducing economic and social inequality, constitutes the most difficult field, as this would imply significant structural changes in the working of the world economy (reverting the flows of benefits in world trade and investment) and the readiness to transfer huge amounts of financial resources. Due to these barriers, human rights are a field where binding international norms (international human rights compacts and a number of other conventions) are implemented to a very limited degree: In the case of civil and political rights this is primarily a matter of defending sovereignty, in the case of economic, social and cultural rights mainly an aspect of the distribution and interaction of economic resources. This also refers to fundamental changes in global health and in the control of communicable diseases as will be shown in the following sections.
In recent decades, due to the increasing global interdependence and greater role of transnational communities of shared norms and political goals [34, 35] , globalization has brought a growing awareness of conflicts and social problems linked to the inequality of global development and has established new transnational political spaces that transcend the aggregation of interests at the national level. The transnational interaction of state and non-state actors produces dynamics and opportunities that tend to limit the political options of nation states. While in the so-called The discourse on global health governance (GHG) has stressed the growing role of non-state actors in global health, concerning political advocacy and direct financial support. Whether global governance institutions could be strong enough to install themselves as effective elements of an emerging system of public rule in the transnational space to provide global public goods in a reliable and impartial way constitutes an important question ( [33] , p. 28; [36] ). The following sections will look in more detail at this role, in particular in consideration of the stability and reliability of this support in contributing to the provision of CCD as a GPG.
GPGs for Global Health: Role of Global Health Governance-Variety of Actors, Self-Organization, Flexibility
The importance of the GPG concept for understanding processes in global health has been thoroughly analyzed by Richard Smith et al. [7] , which is still the most comprehensive text on GPGs for health. There are only a few more recent texts by other authors which use the GPG concept within the context of GHG, in particular Scott Barrett ([37] ; [25] , chapters 2 and 7), Suerie Moon [38] , Joshua Michaud [39] , David Gartner [40] , David
Gleicher and Inge Kaul [41] , Clint Peinhardt and Todd Sandler ( [42] , chapter 6).
In order to approach the meaning of CCD as a complex GPG, it is necessary to look at the most important components, which Woodward Furthermore the authors contrast horizontal and vertical approaches and analyse the respective issues involved in the provision of GPG ( [18] , p. [15] [16] [17] . All these aspects are important for understanding CCD as a GPG (see below Section "Control of Communicable Diseases: A Classical Global Public Good?"). What is missing, however, is a more thorough discussion of the impact of GHG and the dynamics of post-Westphalian global politics on the provision of GPGHs. This is reflected in the definition of GPGs proposed by the authors: a GPG is "a good which it is rational, from a perspective of a group of nations collectively to produce for universal consumption, and for which it is irrational to exclude an individual nation from its consumption, irrespective of whether that nation contributes to its financing" ([18], p. 9). This appears more precise than the definition by Kaul et al. [17] , but it relates only to "nations" as units and thus is rather a definition of international, not of global public goods.
Providing GPGH, however, has been increasingly based on a large number of very different actors (IGOs, states, CSOs, private finance (philanthropic organizations), and hybrid organizations (global health partnerships)) and therefore requires an effective coordination within the global health system, in particular among state and non-state actors [43, 44] . This is basically a matter of global health diplomacy (GHD) as reach far beyond the limitations of the IHR. This will be explored further in the conclusion. Disposing of access goods, in particular access to medical care, might be a precondition for benefitting of GPGs. In some cases, however, "the costeffective supply of access goods may itself be a public good (…), as the cost of providing the access goods to those who do not have them may be no greater than the externalities arising from the additional consumption of the public good" ( [18] , p. 6), e.g., in the case of vaccination programs.
Control of Communicable Diseases: A Classical Global Public Good?
The access issue points to problems of controlling communicable diseases which cannot be seen in isolation from many framework conditions of global health. At least two aspects are important: 
The Eradication of Smallpox-Nurturing a False Hope
With respect to GPGs, the eradication of specific diseases constitutes a quite particular case ( [18] , p. 11f.). While the costs are time-limited, the benefits are permanent, which of course provides a strong incentive to its provision.
The assumption of a limited number of killer diseases which are particularly prone to transmission through international travel and transport underlay the idea of the international sanitary agreements.
Progress in research on vaccines let the eradication of life-threatening Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002 infectious diseases appear feasible, in particular when the disease is worldwide considered a serious threat. This was the situation which allowed the successful eradication of smallpox through a broadly supported WHO campaign; even temporary ceasefires were negotiated to allow vaccinations, e.g., between India and Pakistan during the conflict, which led to the foundation of Bangladesh [49] , in Afghanistan [50] and in a number of other countries [51] . Other CDs are on the list of eradicable diseases, i.e., malaria, yaws, guinea-worm (Dracunciliasis).
So far, smallpox is the only CD affecting humans which has been successfully eradicated, the campaigns against polio and the guinea-worm are close to successful. The Global Malaria Eradication Program was launched in 1955, but suspended in 1969 due to the environmental impact of DDT, and the growing resistance against the broadly-used chloroquine.
In 2007, a consultative process to renew the strategy for malaria eradication was initiated [52] . In the case of polio, there are only three countries with a significant number of endemic cases (Pakistan, Afghanistan, and Nigeria) which are connected to a lack of trust in the vaccination campaign supposedly sparked by information about the CIA using fake vaccination campaigns as a cover to gather DNA samples from Osama Bin Laden's relatives [53] .
In spite of some progress, in recent decades it has become clear that eradication campaigns can only lead to limited progress in the control of communicable diseases. Various origins of communicable diseases can never be eradicated, such as diseases spread from wild animals (HIV/AIDS; Ebola). The effectiveness of medicines cannot be secured forever, mutations of pathogens create anti-microbial resistance (AMR), but also new disease patterns (e.g., in the case of influenza). AMR is a rather new issue in the field of CCD. This supports the proposal that CCD as a public good should not be narrowly defined as the eradication of communicable diseases and controlling the threat of a trans-border spread of outbreaks.
INTERNATIONAL HEALTH REGULATIONS (1969-2005) AS A GPG
Health Security
In recent years, the international control of communicable diseases has been increasingly linked to the issue of health security. WHO defines "health security" as activities that "require, both proactive and reactive, to minimize vulnerability to acute public health events that endanger the collective health of populations living across geographical regions and international boundaries" [54] . The IHR (2005) are considered an important instrument to strengthen health security in the field of CDs ("vulnerability to acute public health events"). There are, however, many concerns expressed about the securitization of health because of its close association to "national security" seen as protection against an external threat [55] [56] [57] . The history of quarantine seems to confirm this viewpoint, as well as the role of the Global Health Security Initiative (GHSI): The GHSI Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002
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In the national context, however, the term "security", also relates to the issue of individual security against violence as well as against social deprivation ("social security"). This is broadened by the concept of "human security", developed in the UNDP Human Development Report 1994 [60] . The concept of human security does not only relate to states as guarantors of security in international relations, but also to global social norms and transnational activities of non-state actors as important determinants of health. Informal transnational norms are often more effective in the implementation of international agreements than negotiations on precise international rules, e.g., in the case of access to treatment of infectious diseases [32] . Though it has been criticized that within the concept of human security "anything and everything could be considered a risk to security" ([61], p. ii), it is significant that it addresses "humanity"-everybody can be the cause of a threat and an object of Conference "Global Health Security 2019" still focused on the threat of biological pathogens (including their use as weapons), but discussed links to more general dimensions of global health ("one health concept", "universal health coverage", "health in all policies") which approximates it to issues of human security [63] (see also below Section "CONCLUSION").
"Health" as a Human Right
Discussing "health security" in terms of human rights, refers to the basic dilemma of providing security against outbreaks. There is the legal obligation to protect the right to health of the public, but on the other hand, there is a need to respect the individual rights of patients and their family members. This reflects another perspective than the idea of "security", which does not deal with potential conflicts of values. Control and Prevention (CDC) [76, 77] . A similar criticism was made by the WHO Ebola Interim Assessment Panel [78] . Only some months after the recognition of the virus and more than 800 deaths in Liberia, Sierra Leone and Guinea as well as some cases in Nigeria, on 8 August 2014 a PHEIC was declared, but the disease could only be stopped after 11,325 people had died [79] ; on 29 March 2016, the emergency was declared to have ended.
In terms of the IHR, the Ebola crisis led the international community to recognise the need to supplement and possibly to revise the IHR (see below). Since August 2018 there has been a new outbreak of Ebola in the eastern part of the DR Congo; with so far 3080 people infected and about 2100 deaths [80] . Again WHO hesitated to declare a PHEIC (done in 17 July 2019) as the outbreak was limited to DRC territory. Due to the availability of effective vaccines, so far the impact seems to be less severe than West Africa. Still, violent conflicts restrict access to the vaccines, and there is no perspective for an imminent end of the epidemic. 
Acute and Chronic Infectious Diseases
There are significant differences between international reactions to acute outbreaks and persistent infectious diseases. The IHR/PHEIC concept relates to infectious diseases which like Cholera, Influenza, SARS, Ebola and Zika are characterized by a rapid international spread prone to become pandemic. However, HIV/AIDS, tuberculosis, malaria and many tropical diseases, which may be called "chronical communicable diseases", are not considered as public health emergencies (see above the WHO explanation for ending the Zika PHEIC). They are progressing more slowly, but then are a constant threat in an infested region as well as of international transmission. The IHR, however, have not been designed to act on such risks even though many countries imposed travel restrictions on people with HIV/AIDS (and thus interfered with international traffic).
This threat has been considerably enhanced through the emergence of drug-resistant strains of pathogens. In the case of the alarming spread of 
TOWARDS AN INTEGRATED CONTROL OF COMMUNICABLE
DISEASES AS A GPG
The attention of CCD on chronic and acute diseases shares one central characteristic that is the vertical, i.e., disease centred approach. This is based on a (mostly implicit) perspective of the eradication of specific diseases as GPGH. During the recent decade, however, the international health community "re-discovered" the importance of Primary Health Care
[92] and the support of health system development [93] . As has been mentioned in the previous sections, a comprehensive control of CDs depends on the universal availability of basic health services. The success of countries with a well-established health system in controlling infectious diseases supports this argument.
Tuberculosis, Malaria and HIV/AIDS Control as in Rich Countries-
How Can This Be Implemented?
During the 19th century, in most of today's high-income countries, TB was the most deadly disease. Systematic case detection (reliable TB tests, notification requirements for physicians, improved hygiene, isolation and Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002 [92] seem to keep these topics apart, the CSDH Report referring only at one place to infectious diseases ( [102] , p. 62). Only a few years later, however, the perspective has been widened towards "universal health coverage" (UHC), to provide universal access to all basic health services [93] .
Furthermore, the launch of the Sustainable Development Goals (SDGs) as well as the rising awareness on the links between communicable and noncommunicable diseases have resulted in a more integrative approach, as has been stressed by various publications [103, 104] , including a WHO publication on the SDGs. Furthermore, attention should also be paid to the so-called "One Health Initiative" that aims at linking human, animal and environmental health as a strategy to fight communicable diseases and thus to strengthen the GPG of CCD, based on the observation that 70% of emerging and reemerging diseases are vector-borne or zoonotic [111] .
Comprehensive CCD should be seen as a composite GPG composed of many specific GPGs related to the spread and general control of many infectious diseases, to medical knowledge and to health system 
FINANCE OF CCD: A TYPICAL COLLECTIVE ACTION PROBLEM
One of the basic characteristics of public goods is their tendency to be underfinanced (see Section "PUBLIC (COMMON) GOODS"), which is exacerbated in the case of GPGs due to the lack of state enforcement.
Otherwise, limited means to provide access to all will endanger the status of CCD as a public good. With respect to vaccination campaigns for the eradication of diseases it has been pointed out that they require a weakestlink technology, the same is true for a full implementation of the IHR Discussing these collective interests in terms of public goods, puts actors under pressure to accept binding obligations to take over specific contributions necessary for implementing the common good (financing investments in their community or supporting poorer communities to take the necessary steps). It is frequently difficult to reach such binding agreements beyond the institutions of the sovereign nation state, even more so in the complex field of GPGs. In this situation, the term (global) governance is obviously more flexible even when it is defined closely linked to the concept of collective goods, slightly modified from a definition Richard Smith proposes: "governance is taken to refer to the actions and means adopted by communities (original: societies) to promote collective action and deliver collective solutions in the pursuit of US state of Washington "with the goal of providing an impartial, evidencebased picture of global health trends to inform the work of policymakers, researchers, and funders" [113], provide detailed information on funding of global health (see Figure 1 for example) [114, 115] . Besides that extended data sources are published by WHO [116] . Therefore, a research focus on the preconditions and mechanisms to implement such commitments is needed which would include analysing the acceptance by a general public of costs not directly linked to a specific benefit for the local population. This is related to an emerging global society [126] characterized by a certain transnational convergence of discourses and elements of transnational norm-building and solidarity expressed through public opinion, mass media, civil society, and political parties [32, 127] .
CONCLUSION: GLOBAL PUBLIC GOODS FOR THE CONTROL OF COMMUNICABLE DISEASES-COMPONENTS OF A STRATEGY
TOWARDS "HEALTH FOR ALL"
This contribution aims at providing a comprehensive view of policies to control communicable diseases through the lens of a GPG approach. The demand for GPGH responds to growing needs in a world characterized by globalization, but providing them, faces great obstacles due to the fragmentation of authority in global politics-in spite of tendencies towards growing international cooperation and transnational communities. Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002
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In two ways, globalization has led to refocussing CDs: In the "developed" world the illusion that these are becoming exclusively "diseases of the poor" had vanished definitely with the spread of HIV/AIDS, and in developing countries the persistent burden of CDs had been recognized as an element of underdevelopment, impeding growth and competitiveness with the "developed" world. These perspectives correspond to two approaches towards controlling CDs: the fundamental remoulding of the IHRs as a mechanism to control the global spread of emerging epidemics and to prevent primarily the emergence of new CDs in Northern countries (and therefore frequently seen under the lens of "health security") and the rise of global partnerships to fight "chronic" CDs in the South as a form of health development aid. This has been accompanied for decades-with varying priorities-by strategies to improve overall healthcare in developing countries, from "Primary Health Care" via "Health System Strengthening (HSS)" to "Universal Health Coverage".
The experiences with the IHR (2005), in particular after the Ebola crisis and obvious deficits in the field of core capacity requirements in poor countries, had been at best mixed. Global Health Security as it is aimed at by the IHR cannot be secured without a basic surveillance and early response capacity in the poorest countries (weakest-link), but the "positive synergies" with HSS and UHC are quite limited [128] . UHC is a human rights-based concept with potentially vast societal externalities; to link this to the political support for GHS/IHR [129] ignores these much more farreaching social obligations. Providing a comprehensive CCD as a GPG (systematically reducing the impact of infectious diseases on health in all world regions) implies the recognition of "one health" as part of a "global responsibility" (contrary to falling back into nationalism). This would lead to a hierarchical structure of GPGs: from global justice via UHC (as "GPGs in construction") to specific forms of international regulation (such as the IHRs) to fight CD transmission and to campaigns to eradicate specific diseases. Raising sufficient financial means for providing CCD as a GPG will remain a great challenge for decades to come; a differentiated discussion of this issue surpassed the frame of this contributions.
The analysis of GPGs for health is basically an analytical endeavour linking the large field of health topics to their inter-and transnational Med One. 2020;5:e200002. https://doi.org/10.20900/mo20200002 Med One 28 of 37 connections, concerning the impact of developments on the local, national and regional levels on the global society on the one hand, of global processes on the local and national spheres and the growing consciousness that many health goals require a global approach and can only be reached through a joint effort. According to Smith and Woodward, the GPG concept "is not appropriate as an organizing principle or a prioritization mechanism-while it can tell us how to achieve desired outcomes in particular areas, it cannot, by itself, tell us what we should do" ([107], p. 279). Recently, the link between various prioritary WHO programmes (UHC, controlling "threats from high-impact health emergencies", i.e., strengthening the IHR, ...) and the SDGs produced a new demand for a more comprehensive view of interdependencies between policy fields and for intensifying cooperation in particular to improve the financial basis for these programmes. The concept of (global) public/common goods for health has been "rediscovered" as a useful tool to better analyse the benefits of and the political environment for UHC and to push for a health financing reform: the WHO has recently established a "Financing Common Goods for Health technical expert group" [130] , which in December 2019 published a special issue of the review Health Systems and
Reform on "Financing Common Goods for Health: Fundamental for
Health, the Foundation for UHC" [131] . By looking through the lens of a global public good at the frequently narrow and fragmented analyses on controlling infectious diseases, this article intends to contribute to a more comprehensive treatment of this field of global health. For fully exploiting this approach a much more detailed analysis of specific public goods for infection control is needed.
